Sino BiologicalInc 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Zhang Jie

최고 경영자

CN¥2.7m

총 보상

CEO 급여 비율	n/a
CEO 임기	6.8yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	4.7yrs

최근 관리 업데이트

Recent updates

Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 04

Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up

Sep 30

Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00

May 21

Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce

May 08

Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders

May 06

CEO

Zhang Jie (51 yo)

6.8yrs

테뉴어

CN¥2,740,800

보상

Mr. Zhang Jie, Ph D, serves as R&D Director of Sino Biological Inc. He is General Manager of Sino Biological Inc since 2018 and is its MD & Director. Mr. Zhang graduated from Beijing Medical Sciences Unive...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Zhang Jie	GM, MD, R&D Director & Director	4.7yrs	CN¥2.74m	데이터 없음
Tao Feng	CFO, Secretary to the Board & Non-Independent Director	4.7yrs	CN¥1.20m	데이터 없음
Liangzhi Xie	Founder	4.7yrs	데이터 없음	55.81% CN¥ 4.4b
Daniel I. Wang	Chairman of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Yanmin Tang	Non-Independent Director	4.7yrs	데이터 없음	데이터 없음
Baiyang Sheng	Non-Independent Director	1.7yrs	데이터 없음	데이터 없음
Xiaofang Chen	Non-Independent Director	4.7yrs	데이터 없음	데이터 없음
Shizhou Yin	Independent Director	4.7yrs	CN¥120.00k	데이터 없음
Changyuan Yu	Independent Director	4.7yrs	CN¥120.00k	데이터 없음
Yong You	Independent Director	1.7yrs	CN¥90.00k	데이터 없음
Jing Wang	Chairman of the Supervisory Board	4.7yrs	데이터 없음	데이터 없음
Xiaotong Wang	Supervisor	1.2yrs	데이터 없음	데이터 없음

4.7yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 이사회: 301047 의 이사회는 경험(평균 재직 기간 4.7 년)으로 간주됩니다.

Sino BiologicalInc 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Sino Biological,Inc., Annual General Meeting, May 14, 2024

Sino Biological Inc., Annual General Meeting, Mar 21, 2022

Recent updates

Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings

Third quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.54 in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up

Sino Biological,Inc. to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 27%

Consensus EPS estimates fall by 37%

Price target decreased by 27% to CN¥70.00

Second quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.40 in 2Q 2023)

New minor risk - Share price stability

Sino Biological,Inc. to Report First Half, 2024 Results on Aug 10, 2024

Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00

Dividend of CN¥2.00 announced

Consensus revenue estimates fall by 13%

Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce

Investor sentiment improves as stock rises 25%

Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders

Sino Biological,Inc., Annual General Meeting, May 14, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Revenue and earnings growth

Sino Biological,Inc. to Report Q1, 2024 Results on Apr 29, 2024

Sino Biological,Inc. (SZSE:301047) commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 19, 2024.

Investor sentiment improves as stock rises 19%

Sino Biological,Inc. to Report Fiscal Year 2023 Results on Apr 24, 2024

Third quarter 2023 earnings released: EPS: CN¥0.54 (vs CN¥0.65 in 3Q 2022)

Sino Biological,Inc. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.40 (vs CN¥1.15 in 2Q 2022)

Price target decreased by 7.1% to CN¥117

Sino Biological,Inc Approves the Final Cash Dividend for the Year 2022, Payable on 24 May 2023

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improved over the past week

Price target decreased to CN¥135

Third quarter 2022 earnings released: EPS: CN¥0.65 (vs CN¥1.06 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.15 (vs CN¥1.14 in 2Q 2021)

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus forecasts updated

Sino Biological Inc., Annual General Meeting, Mar 21, 2022

Sino Biological Inc. Proposes Cash Dividend for 2021

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥2.01 (vs CN¥7.39 in 3Q 2020)

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령